147 related articles for article (PubMed ID: 38449380)
1. Multiple Primary Cancers With Hematologic Malignancies and Germline Predisposition: A Case Series.
Yun J; Lee DS; Lee S; Yun H
Ann Lab Med; 2024 Sep; 44(5):446-449. PubMed ID: 38449380
[TBL] [Abstract][Full Text] [Related]
2. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
Atluri H; Gerstein YS; DiNardo CD
Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
[TBL] [Abstract][Full Text] [Related]
3. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
Andrés-Zayas C; Suárez-González J; Rodríguez-Macías G; Dorado N; Osorio S; Font P; Carbonell D; Chicano M; Muñiz P; Bastos M; Kwon M; Díez-Martín JL; Buño I; Martínez-Laperche C
Mol Oncol; 2021 Sep; 15(9):2273-2284. PubMed ID: 33533142
[TBL] [Abstract][Full Text] [Related]
5. Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies.
Schlegelberger B; Mecucci C; Wlodarski M
Fam Cancer; 2021 Oct; 20(4):295-303. PubMed ID: 34057692
[TBL] [Abstract][Full Text] [Related]
6. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer.
Singhal D; Hahn CN; Feurstein S; Wee LYA; Moma L; Kutyna MM; Chhetri R; Eshraghi L; Schreiber AW; Feng J; Wang PP; Babic M; Parker WT; Gao S; Moore S; Das S; Thomas D; Pattnaik S; Brown AL; D'Andrea RJ; Poplawski NK; Thomas D; Scott HS; Godley LA; Hiwase DK
Leukemia; 2021 Nov; 35(11):3245-3256. PubMed ID: 33850299
[TBL] [Abstract][Full Text] [Related]
7. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
Stubbins RJ; Korotev S; Godley LA
Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.
Yasuda T; Sanada M; Nishijima D; Kanamori T; Iijima Y; Hattori H; Saito A; Miyoshi H; Ishikawa Y; Asou N; Usuki K; Hirabayashi S; Kato M; Ri M; Handa H; Ishida T; Shibayama H; Abe M; Iriyama C; Karube K; Nishikori M; Ohshima K; Kataoka K; Yoshida K; Shiraishi Y; Goto H; Adachi S; Kobayashi R; Kiyoi H; Miyazaki Y; Ogawa S; Kurahashi H; Yokoyama H; Manabe A; Iida S; Tomita A; Horibe K
Cancer Sci; 2020 Sep; 111(9):3367-3378. PubMed ID: 32619037
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea.
Yun J; Song H; Kim SM; Kim S; Kwon SR; Lee YE; Jeong D; Park JH; Kwon S; Yun H; Lee DS
Hum Genomics; 2023 Feb; 17(1):13. PubMed ID: 36814285
[TBL] [Abstract][Full Text] [Related]
10. Germline Genetic Predisposition to Hematologic Malignancy.
Furutani E; Shimamura A
J Clin Oncol; 2017 Mar; 35(9):1018-1028. PubMed ID: 28297620
[TBL] [Abstract][Full Text] [Related]
11. Multiple primary tumors as an indicator for p16INK4a germline mutations in pancreatic cancer patients?
Gerdes B; Bartsch DK; Ramaswamy A; Kersting M; Wild A; Schuermann M; Frey M; Rothmund M
Pancreas; 2000 Nov; 21(4):369-75. PubMed ID: 11075991
[TBL] [Abstract][Full Text] [Related]
12. Germline Predisposition in Hematologic Malignancies: Testing, Management, and Implications.
Godley LA; DiNardo CD; Bolton K
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432218. PubMed ID: 38768412
[TBL] [Abstract][Full Text] [Related]
13. Identifying potential germline variants from sequencing hematopoietic malignancies.
Kraft IL; Godley LA
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):219-227. PubMed ID: 33275754
[TBL] [Abstract][Full Text] [Related]
14. Identifying potential germline variants from sequencing hematopoietic malignancies.
Kraft IL; Godley LA
Blood; 2020 Nov; 136(22):2498-2506. PubMed ID: 33236764
[TBL] [Abstract][Full Text] [Related]
15. Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
Lee NY; Hum M; Zihara S; Wang L; Myint MK; Lim DW; Toh CK; Skanderup A; Samol J; Tan MH; Ang P; Lee SC; Tan EH; Lai GGY; Tan DSW; Yap YS; Lee ASG
Hum Genomics; 2023 Jul; 17(1):66. PubMed ID: 37461096
[TBL] [Abstract][Full Text] [Related]
16. Myeloid Malignancies: Recognizing the Risk of Germline Predisposition and Supporting Patients and Families.
Friend P; Mahon SM
Clin J Oncol Nurs; 2021 Oct; 25(5):519-522. PubMed ID: 34533515
[TBL] [Abstract][Full Text] [Related]
17. Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci.
Carraway HE; LaFramboise T
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101191. PubMed ID: 33038980
[TBL] [Abstract][Full Text] [Related]
18. Identifying possible germline variants from tumor-only sequencing of hematological malignancies.
Shao J; Subedi S; Pepper K; Badgett S; Christensen PA; Hendrickson HL; Thomas JS; Olsen RJ; Li Z
Leuk Lymphoma; 2021 Feb; 62(2):482-485. PubMed ID: 33054462
[No Abstract] [Full Text] [Related]
19. Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT).
Clark A; Thomas S; Hamblin A; Talley P; Kulasekararaj A; Grinfeld J; Speight B; Snape K; McVeigh TP; Snowden JA
Br J Haematol; 2023 Apr; 201(1):35-44. PubMed ID: 36786081
[TBL] [Abstract][Full Text] [Related]
20. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]